Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.03.21.001586: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Coronavirus subtyping and Mutation Analysis: All assembled query genomes in FASTA format were analyzed using Genome Detective Coronavirus Typing Tool (version 1.1.3)(5) which allows quick identification and characterization of novel coronavirus genomes.
    Mutation Analysis
    suggested: None
    MSA was performed using online CLUSTAL-OMEGA software.
    CLUSTAL-OMEGA
    suggested: None
    Neighbor joining method with bootstrap value of 1000 replicates was used for the construction of consensus tree using MEGA software(6) (10.1.7 version).
    MEGA
    suggested: (Mega BLAST, RRID:SCR_011920)
    (Figure 1(b)) To identify potential host microRNA target sites in the virus genome sequences, we have used miRanda (3.3 a version)(12, 13) software, with an energy threshold of −20 kcal/mol.
    miRanda
    suggested: (miRanda, RRID:SCR_017496)
    We also used psRNATarget server to compare the predicted targets by the two methods(14).
    psRNATarget
    suggested: (psRNATarget, RRID:SCR_013321)
    Immunogenic properties analysis: All the genes and protein sequences for SARS-CoV2 were retrieved from ViPR database.
    ViPR
    suggested: (vipR, RRID:SCR_010685)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • No conflict of interest statement was detected. If there are no conflicts, we encourage authors to explicit state so.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.